← Back to headlines
Medtronic to Acquire SPR Therapeutics for Approximately $650 Million
Medical technology company Medtronic is set to acquire SPR Therapeutics in a deal valued at around $650 million. The acquisition will expand Medtronic's portfolio in the healthcare sector.
20 May, 13:45 — 20 May, 13:45
Sources
Showing 1 of 1 sources
